Vaccination in patients with immunosuppression

Turk Pediatri Arsivi

Volumn 49, Issue 3, 2014, Pages 181-185

  Arvas, Ahmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Contraindication; Immune deficiency; Inactive vaccines; Live vaccines

Indexed keywords

AZATHIOPRINE; BCG VACCINE; CHICKENPOX VACCINE; CORTICOSTEROID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS VACCINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; METHOTREXATE; MONOCLONAL ANTIBODY; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PREDNISOLONE; RITUXIMAB; ROTAVIRUS VACCINE; VIRUS VACCINE;

ARTICLE; ASPLENIA; ASYMPTOMATIC DISEASE; CANCER CHEMOTHERAPY; CD4 LYMPHOCYTE COUNT; CHEDIAK HIGASHI SYNDROME; CHRONIC ARTHRITIS; CHRONIC GRANULOMATOUS DISEASE; CHRONIC LIVER DISEASE; COMBINED IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HAEMOPHILUS INFECTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; LEUKEMIA; LOW DRUG DOSE; LYMPHOMA; MENINGOCOCCOSIS; NEUROLOGIC DISEASE; NEUTROPENIA; ORGAN TRANSPLANTATION; PHAGOCYTE DYSFUNCTION; REMISSION; RHEUMATIC DISEASE; VACCINATION;

EID: 84907271088     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: 10.5152/tpa.2014.2206     Document Type: Article

References (11)

1. Ljugman P. Vaccination ofimmunocompromised hosts. In: Vaccines. Plotkin SA, Orenstein WA, Offit PAü, (eds). 6th edition. Elsevier Inc: Saunders, 2013; 1243-56.
2. American Academy of Pediatrics. Immunization in special clinical circumtances. In: Red Book 2012 Report of the Committee on Infectious Diseases. Pickering LK, Baker CJ, Kimberlin DW, Long SS, (eds). 29th edition. Elk Grove Village (II.) American Academy of Pediatrics, 2012; 74-90.
3. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: 309-18.
4. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60: 1-64.
5. Shearer WT, Fleisher TA, Buckley RH, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 2014; 133: 961-6.
6. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-238.
7. Campbell AL, Herold BC. Immunization of pediatric solid organ transplantation candidates: immunization in transplant candidates. Pediatr Transplant 2005; 9: 952-61.
8. Davies K, Woo P. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) 2002; 41: 937-41.
9. Heijstek MW, Ott de Bruin LM, Bijl M, et al. EULAR recommendation for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 2011; 70: 1704-12.
10. Bingham CO, Looney RJ, Deodhar A, et al. Immunization responses in rheumatic arthritis patients treated with rituximab: results from a controlled clinical trial. Arhtritis Rheum 2010; 62: 64-74.
11. Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine 2001; 28: 5109-13.